140 related articles for article (PubMed ID: 9784910)
1. A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
Levy P; Lechat P; Leizorovicz A; Levy E
Cardiovasc Drugs Ther; 1998 Jul; 12(3):301-5. PubMed ID: 9784910
[TBL] [Abstract][Full Text] [Related]
2. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II).
Eur Heart J; 2001 Jun; 22(12):1021-31. PubMed ID: 11428837
[TBL] [Abstract][Full Text] [Related]
3. A cost minimisation analysis of cardiac failure treatment in the UK using CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
Malek M; Cunningham-Davis J; Malek L; Paschen B; Tavakoli M; Zabihollah M; Davey P
Int J Clin Pract; 1999; 53(1):19-23. PubMed ID: 10344061
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation; 1994 Oct; 90(4):1765-73. PubMed ID: 7923660
[TBL] [Abstract][Full Text] [Related]
5. [Cost effectiveness of bisoprolol in heart failure. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study (CIBIS) for Germany].
Schädlich PK; Paschen B; Brecht JG
Med Klin (Munich); 1997 Aug; 92(8):499-504. PubMed ID: 9340476
[TBL] [Abstract][Full Text] [Related]
6. [Bisprolol in heart failure: efficacy and costs in a French setting according to CIBIS II].
Lévy P; Mérot JL; Lechat P; Lévy E; Bogillot O
Therapie; 2001; 56(4):421-5. PubMed ID: 11677866
[TBL] [Abstract][Full Text] [Related]
7. Bisoprolol: a review of its use in chronic heart failure.
McGavin JK; Keating GM
Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
[TBL] [Abstract][Full Text] [Related]
8. [Cost effectiveness of bisoprolol in treatment of heart failure in Germany. An analysis based on the CIBIS-II study].
Szucs TD; Schwenkglenks M; Paschen B; Follath F
Med Klin (Munich); 2000 Dec; 95(12):663-71. PubMed ID: 11198553
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany.
Schädlich PK; Paschen B; Brecht JG
Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):147-55. PubMed ID: 10176149
[TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness of bisoprolol in chronic heart failure].
Ekman M; Zethraeus N; Dahlström U; Höglund C
Lakartidningen; 2002 Feb; 99(7):646-50. PubMed ID: 11887711
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trial.
Ekman M; Zethraeus N; Jönsson B
Pharmacoeconomics; 2001; 19(9):901-16. PubMed ID: 11700777
[TBL] [Abstract][Full Text] [Related]
12. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of bisoprolol for heart failure.
Varney S
Eur J Heart Fail; 2001 Jun; 3(3):365-71. PubMed ID: 11378009
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of bisoprolol treatment for heart failure.
Di Stasi F; Scalone L; De Portu S; Menditto E; Mantovani LG
Ital Heart J; 2005 Dec; 6(12):950-5. PubMed ID: 16502708
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
Lechat P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
[TBL] [Abstract][Full Text] [Related]
16. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.
Lechat P; Hulot JS; Escolano S; Mallet A; Leizorovicz A; Werhlen-Grandjean M; Pochmalicki G; Dargie H
Circulation; 2001 Mar; 103(10):1428-33. PubMed ID: 11245648
[TBL] [Abstract][Full Text] [Related]
17. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
[TBL] [Abstract][Full Text] [Related]
18. Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): a study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risks.
Funck-Brentano C; Lancar R; Le Heuzey JY; Lardoux H; Soubrié C; Lechat P
Am Heart J; 2000 Feb; 139(2 Pt 1):262-71. PubMed ID: 10650299
[TBL] [Abstract][Full Text] [Related]
19. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study.
Leizorovicz A; Lechat P; Cucherat M; Bugnard F
Am Heart J; 2002 Feb; 143(2):301-7. PubMed ID: 11835035
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).
Lechat P; Escolano S; Golmard JL; Lardoux H; Witchitz S; Henneman JA; Maisch B; Hetzel M; Jaillon P; Boissel JP; Mallet A
Circulation; 1997 Oct; 96(7):2197-205. PubMed ID: 9337190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
